journal article·2026-01-09Open access

Establishment of Vasculature in Hyper-Crosslinked Carbohydrate Polymer as Scaffolding for Tissue Engineering and Regeneration

Evan T. Lee, Plamena M. Koleva, Kee D. Kim, Cynthia A. Batchelder

Applied Sciences· Volume 16· Issue 2

Abstract

Vascularization is one of the key components of tissue engineering and must accompany the ingrowth of new tissues to establish an environment conducive to repair and regeneration of damaged tissue. The overarching objective of this study was to investigate whether the hyper-crosslinked carbohydrate polymer (HCCP) could promote the establishment of new vasculature compared to hydroxyapatite/beta-tricalcium phosphate (HA/β-TCP), which is widely used in orthopedic procedures. Sprague Dawley rats (n = 12) were implanted subcutaneously with HCCP or HA/β-TCP and evaluated histologically for the ingrowth of new vasculature at 3, 14, and 28 days post-implantation. HCCP showed significantly greater levels of vascularization when compared to HA/β-TCP at all time points evaluated (p < 0.05). HA/β-TCP showed transient inflammation at 14 days post-implantation, whereas minimal immune activities were noted in HCCP. These findings suggest that HCCP promotes the establishment of new vasculature without a significant immune response.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Infectious Aortic and Vascular Conditions · Wound Healing and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Neurological Surgery, University of California Davis Medical Center, Sacramento, CA 95816, USA

Molecular Matrix, Inc., Rancho Cordova, CA 95670, USA

Funding

Molecular Matrix, Inc.

References (47)

Show source-provided references
1. Advancements in drug-loaded hydrogel systems for bone defect repair10.1016/j.reth.2023.12.010 ↗
2. FDA-approved bone grafts and bone graft substitute devices in bone regeneration10.1016/j.msec.2021.112466 ↗
3. Autologous bone graft: Is it still the gold standard?10.1016/j.injury.2021.01.043 ↗
4. Autograft, Allograft, and Bone Graft Substitutes: Clinical Evidence and Indications for Use in the Setting of Orthopaedic Trauma Surgery10.1097/BOT.0000000000001420 ↗
5. Complications of iliac crest bone graft harvesting10.1097/00003086-199608000-00037 ↗
6. Infectious disease transmission during organ and tissue transplantation10.3201/eid1808.120277 ↗
7. Bone Graft Options in Spinal Fusion: A Review of Current Options and the Use of Mesenchymal Cellular Bone Matrices10.1016/j.wneu.2021.11.130 ↗
8. Osteoblast migration in vertebrate bone10.1111/brv.12345 ↗
9. Prospects for osteoprogenitor stem cells in fracture repair and osteoporosis10.1097/MOT.0b013e328333d52c ↗
10. Composite implantation of mesenchymal stem cells with endothelial progenitor cells enhances tissue-engineered bone formation10.1002/jbm.a.32142 ↗
11. The role of the vessels in osteogenesis10.1097/00006534-196402000-00034 ↗
12. Angiogenesis is required for successful bone induction during distraction osteogenesis10.1359/JBMR.050301 ↗
13. Prevention of fracture healing in rats by an inhibitor of angiogenesis10.1016/S8756-3282(01)00608-1 ↗
14. Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage10.1046/j.1469-7580.1999.19440519.x ↗
15. Fibroblasts inhibit osteogenesis by regulating nuclear-cytoplasmic shuttling of YAP in mesenchymal stem cells and secreting DKK110.1186/s40659-023-00481-y ↗
16. Role of angiogenesis in bone repair10.1016/j.abb.2014.07.006 ↗
17. Delayed unions and nonunions of open tibial fractures: Correlation with arteriography results10.1097/00003086-199405000-00029 ↗
18. Angiogenesis in bone regeneration10.1016/j.injury.2011.03.035 ↗
19. The vascularity of atrophic non-unions10.1016/S0020-1383(01)00153-X ↗
20. The synergistic effect of autograft and BMP-7 in the treatment of atrophic nonunions10.1007/s11999-009-0846-2 ↗
21. Polymer of proline analogue with sustained antifibrotic activity in lung fibrosis10.1164/ajrccm.155.4.9105084 ↗
22. Muzzarelli, Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone10.1016/j.carbpol.2008.11.002 ↗
23. Polymers for pro- and anti-angiogenic therapy10.1016/j.biomaterials.2006.12.029 ↗
24. Hyper-Crosslinked Carbohydrate Polymer for Repair of Critical-Sized Bone Defects10.1089/biores.2019.0021 ↗
25. Brief review of models of ectopic bone formation10.1089/scd.2011.0517 ↗
26. Porosity of 3D biomaterial scaffolds and osteogenesis10.1016/j.biomaterials.2005.02.002 ↗
27. Geometric analysis of porous bone substitutes using micro-computed tomography and fuzzy distance transform10.1016/j.actbio.2009.08.007 ↗
28. Synergistic hydroxyl radical formation, system XC- inhibition and heat shock protein crosslinking tango in ferrotherapy: A prove-of-concept study of “sword and shield” theory10.1016/j.mtbio.2022.100353 ↗
29. Vascularization in tissue engineering10.1016/j.tibtech.2008.04.009 ↗
30. Vascularization in tissue engineering: Angiogenesis versus inosculation10.1159/000336876 ↗
31. Vascularization strategies for tissue engineering10.1089/ten.teb.2009.0085 ↗
32. Guided bone regeneration using beta-tricalcium phosphate and leucocyte platelet-rich fibrin versus a novel biodegradable urethane composite in critical-size osseous defects in rabbit tibia: Histologic results of a pilot study10.1016/j.aanat.2025.152672 ↗
33. Glycosylation-enabled chemoselective growth factor engineering for biomaterial functionalization10.1016/j.actbio.2025.09.057 ↗
34. The correlation between gene expression of proinflammatory markers and bone formation during osseointegration with titanium implants10.1016/j.biomaterials.2010.09.011 ↗
35. Inflammatory responses to orthopaedic biomaterials in the murine air pouch10.1016/S0142-9612(01)00134-X ↗
36. The role of macrophage phenotype in vascularization of tissue engineering scaffolds10.1016/j.biomaterials.2014.02.012 ↗
37. Synthetic polymer scaffolds for tissue engineering10.1039/b811392k ↗
38. Macrophages, foreign body giant cells and their response to implantable biomaterials10.3390/ma8095269 ↗
39. Foreign body reaction to biomaterials10.1016/j.smim.2007.11.004 ↗
40. Macrophage fusion and MNGCs of inflammation10.1007/978-94-007-0763-4_7 ↗
41. The physicochemical properties of the solidification of calcium phosphate cement10.1002/jbm.b.20032 ↗
42. The construction of three-dimensional micro-fluidic scaffolds of biodegradable polymers by solvent vapor based bonding of micro-molded layers10.1016/j.biomaterials.2006.11.002 ↗
43. Engineering vascularized tissue10.1038/nbt0705-821 ↗
44. Brum, I.S., Frigo, L., Ribeiro da Silva, J.F., Ciambarella, B.T., Nascimento, A.L.R., Pereira, M.J.S., Elias, C.N., and de Carvalho, J.J. (2025). Comparison Between Nano-Hydroxyapatite/Beta-Tricalcium Phosphate Composite and Autogenous Bone Graft in Bone Regeneration Applications: Biochemical Mechanisms and Morphological Analysis. Int. J. Mol. Sci., 26.10.20944/preprints202410.1932.v1 ↗
45. De Mori, A., Karali, A., Daskalakis, E., Hing, R., Da Silva Bartolo, P.J., Cooper, G., and Blunn, G. (2024). Poly-ε-Caprolactone 3D-Printed Porous Scaffold in a Femoral Condyle Defect Model Induces Early Osteo-Regeneration. Polymers, 16.10.3390/polym16010066 ↗
46. Maevskaia, E., Guerrero, J., Ghayor, C., Bhattacharya, I., and Weber, F.E. (2024). Functionalization of Ceramic Scaffolds with Exosomes from Bone Marrow Mesenchymal Stromal Cells for Bone Tissue Engineering. Int. J. Mol. Sci., 25.10.3390/ijms25073826 ↗
47. Ehret, C., Aid, R., Dos Santos, B.P., Rey, S., Letourneur, D., Amédée Vilamitjana, J., and de Mones, E. (2023). Bone Regeneration in Small and Large Segmental Bone Defect Models after Radiotherapy Using Injectable Polymer-Based Biodegradable Materials Containing Strontium-Doped Hydroxyapatite Particles. Int. J. Mol. Sci., 24.10.3390/ijms24065429 ↗